Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 900 participants.

Also called NCT06911632

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 900 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06911632
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06911632. Randomized; no masking; primary purpose diagnostic. Start 2025-07-23 (actual); primary completion 2028-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Acronym
MOMENTOUS
Condition
Interstitial Lung Disease (ILD)
Intervention (Device)
ECG-based AI Device - Results Returned to Investigator
Intervention (Procedure)
Echocardiogram and Right Heart Catheterization
Intervention (Device)
ECG-based AI Device - Results Not Returned to Investigator
Lead sponsor
Tempus AI (class: industry)
Collaborator
United Therapeutics (class: industry)

Record details

Record id
cardio:ct-nct06911632
Content hash
86757f876e2926ce6476a429ade216957c0f8489e48b82b681c6b2ddd2d25e1f